NEA Management Company, LLC Q3 2016 Filing
Filed November 10, 2016
Portfolio Value
$2.2T
Holdings
39
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (39 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —TESARO INC | 10,275,113 | $1.0T | 46.23% | |
| 2 | ARDXARDELYX INC | 14,083,582 | $182.2B | 8.18% | |
| 3 | —DERMIRA INC | 3,506,649 | $119.2B | 5.35% | |
| 4 | GRPNCHFGROUPON INC | 20,075,762 | $103.4B | 4.64% | |
| 5 | SENS1GBPSENSEONICS HOLDINGS INC | 26,303,189 | $102.6B | 4.60% | |
| 6 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 9,880,999 | $69.7B | 3.13% | |
| 7 | NVROEURNEVRO CORP | 660,428 | $68.9B | 3.09% | |
| 8 | —EPIZYME INC | 6,260,851 | $61.6B | 2.77% | |
| 9 | GLYCEURGLYCOMIMETICS INC | 8,584,128 | $61.4B | 2.75% | |
| 10 | —PROTEOSTASIS THERAPEUTICS INC | 3,556,778 | $55.5B | 2.49% | |
| 11 | LXRXLEXICON PHARMACEUTICALS INC | 2,382,286 | $43.0B | 1.93% | |
| 12 | CLVSEURCLOVIS ONCOLOGY INC | 1,139,890 | $41.1B | 1.84% | |
| 13 | —LOXO ONCOLOGY INC | 1,289,420 | $33.8B | 1.52% | |
| 14 | —CARE COM INC | 3,260,989 | $32.5B | 1.46% | |
| 15 | —ENDOLOGIX INC | 2,490,204 | $31.9B | 1.43% | |
| 16 | —AEROHIVE NETWORKS INC | 4,681,455 | $28.5B | 1.28% | |
| 17 | —TREVENA INC | 3,811,691 | $25.7B | 1.15% | |
| 18 | —ACHAOGEN INC | 4,715,128 | $22.6B | 1.01% | |
| 19 | —CASCADIAN THERAPEUTICS INC | 10,750,000 | $17.6B | 0.79% | |
| 20 | —TRACON PHARMACEUTICALS INC | 1,889,652 | $12.6B | 0.57% | |
| 21 | RIGLUSDRIGEL PHARMACEUTICALS INC | 3,243,150 | $11.9B | 0.53% | |
| 22 | —STRONGBRIDGE BIOPHARMA PLC | 2,141,308 | $11.2B | 0.50% | |
| 23 | —AVEO PHARMACEUTICALS INC | 10,362,694 | $9.2B | 0.41% | |
| 24 | AUPHAURINIA PHARMACEUTICALS INC | 2,546,843 | $7.7B | 0.34% | |
| 25 | —MIRNA THERAPEUTICS INC | 2,974,811 | $5.9B | 0.26% | |
| 26 | —SUNESIS PHARMACEUTICALS INC | 1,298,274 | $5.7B | 0.25% | |
| 27 | —DASAN ZHONE SOLUTIONS INC | 4,781,290 | $5.5B | 0.24% | |
| 28 | —ARQULE INC | 2,520,316 | $4.5B | 0.20% | |
| 29 | —ARCA BIOPHARMA INC | 1,460,209 | $4.1B | 0.19% | |
| 30 | —AKARI THERAPEUTICS PLC | 452,167 | $3.8B | 0.17% | |
| 31 | CSBRCHAMPIONS ONCOLOGY INC | 1,562,500 | $2.6B | 0.12% | |
| 32 | —CERECOR INC | 595,435 | $2.5B | 0.11% | |
| 33 | —ROKA BIOSCIENCE INC | 3,220,433 | $2.2B | 0.10% | |
| 34 | —XTERA COMMUNICATIONS INC | 3,631,537 | $2.0B | 0.09% | |
| 35 | —ZOSANO PHARMA CORP | 2,052,809 | $1.6B | 0.07% | |
| 36 | —OREXIGEN THERAPEUTICS INC | 370,900 | $1.2B | 0.06% | |
| 37 | —AGILE THERAPEUTICS PLC | 133,488 | $932.0M | 0.04% | |
| 38 | —PARATEK PHARMACEUTICALS INC | 66,245 | $862.0M | 0.04% | |
| 39 | —CATALYST BIOSCIENCES INC | 652,380 | $789.0M | 0.04% |